Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HeraMED Ltd. ( (AU:HMD) ) just unveiled an update.
HeraMED Ltd. has applied to the ASX for quotation of 2,633,860 new ordinary fully paid shares under the ticker HMD. The securities, issued on 12 March 2026 following the exercise or conversion of existing options or other convertible instruments, will expand the company’s listed capital base and may modestly affect existing shareholders’ dilution and trading liquidity.
The move reflects routine capital management activity as HeraMED converts previously issued rights into listed equity. While the announcement does not detail use of funds or strategic initiatives linked to these shares, the additional quoted securities could support improved market depth and facilitate future corporate or financing transactions.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
HeraMED Ltd. is an Australian-listed company trading under the ASX code HMD. The specific industry and products or services of the company are not described in the disclosed document.
YTD Price Performance: 11.11%
Average Trading Volume: 654,880
Technical Sentiment Signal: Buy
Current Market Cap: A$44.55M
For a thorough assessment of HMD stock, go to TipRanks’ Stock Analysis page.